Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in CYTK — Cytokinetics Inc

CIK 886982 NEW YORK, NY
Back to CYTK Full portfolio

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$150,069,678
+$4,688,172 QoQ
Shares Held
1,761,588
-20.1% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#14
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Derivatives in CYTK

reported options exposure · as of Jun 30, 2026
CallValue
$2,819,789
CallShares
33,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. CYTK ranks #17 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in CYTK

Export CSV
41 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,819,789 33,100
2026-06-30 $150,069,678 1,761,588
2026-03-31 $145,381,506 2,205,758
2026-03-31 $16,477,500 250,000
2025-12-31 $150,696,481 2,371,679
2025-12-31 $11,843,856 186,400
2025-12-31 $2,223,900 35,000
2025-09-30 $1,648,800 30,000
2025-09-30 $89,844,374 1,634,723
2025-06-30 $42,092,397 1,273,983
2025-06-30 $1,295,168 39,200
2025-03-31 $365,729 9,100
2025-03-31 $54,777,281 1,362,958
2025-03-31 $421,995 10,500
2024-12-31 $56,703,472 1,205,431
2024-09-30 $62,556,857 1,184,789
2024-09-30 $2,508,000 47,500
2024-06-30 $1,051,092 19,400
2024-06-30 $3,537,954 65,300
2024-06-30 $61,665,182 1,138,154
2024-03-31 $48,477,487 691,449
2024-03-31 $1,261,980 18,000
2024-03-31 $1,261,980 18,000
2023-12-31 $68,081,419 815,444
2023-12-31 $16,873,329 202,100
2023-09-30 $20,900,396 709,450
2023-06-30 $36,085,483 1,106,238
2023-03-31 $37,812,498 1,074,524
2022-12-31 $41,707,700 910,251
2022-09-30 $32,853,169 678,084
2022-06-30 $18,495,885 470,753
2022-03-31 $24,347,827 661,446
2021-12-31 $25,465,727 558,704
2021-09-30 $35,184,778 984,465
2021-06-30 $11,131,934 562,503
2021-03-31 $18,730,998 805,288
2020-12-31 $17,117,815 823,764
2020-09-30 $19,459,691 898,831
2020-09-30 $2,323,045 107,300
2020-06-30 $19,201,040 814,639
2020-03-31 $5,686,894 482,349

Report a Problem

Category
Description
Email (optional, for follow-up)